Skip to main content
. Author manuscript; available in PMC: 2015 Nov 2.
Published in final edited form as: C R Biol. 2012 Nov 9;336(3):177–182. doi: 10.1016/j.crvi.2012.09.006

Table 1.

Clinical and laboratory indications for considering hydroxyurea therapy in children with sickle cell anemia.

Clinical
 Painful episodes
 Dactylitis
 Acute Chest Syndrome
Laboratory
 Severe anemia
 Low HbF
 High White Blood Cell count
 Elevated LDH
Organ dysfunction
 Hypoxemia
 Proteinuria
 Elevated transcranial Doppler (TCD) velocities
 Cerebrovascular disease
Miscellaneous
 Poor growth and development
 Sibling on therapy
 Parental request